A polymorphism in New Zealand inbred mouse strains that inactivates phosphatidylcholine transfer protein

[1]  K. Wirtz.  Phospholipid transfer proteins in perspective , 2006, FEBS letters.

[2]  D. Vance,et al.  Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism. , 2006, Vascular pharmacology.

[3]  D. Cohen,et al.  Phosphatidylcholine transfer protein regulates size and hepatic uptake of high-density lipoproteins. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[4]  D. Vance,et al.  Pharmacogenetic analysis of rosiglitazone-induced hepatosteatosis in new mouse models of type 2 diabetes. , 2005, Diabetes.

[5]  I. Tabas,et al.  Decreased lipid efflux and increased susceptibility to cholesterol-induced apoptosis in macrophages lacking phosphatidylcholine transfer protein. , 2005, The Biochemical journal.

[6]  D. Cohen,et al.  Altered hepatic cholesterol metabolism compensates for disruption of phosphatidylcholine transfer protein in mice. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[7]  P. Novikoff,et al.  Impaired response of biliary lipid secretion to a lithogenic diet in phosphatidylcholine transfer protein-deficient mices⃞s⃞ The online version of this article (available at http://www.jlr.org) contains an additional table. Published, JLR Papers in Press, December 1, 2004. DOI 10.1194/jlr.M400387-JL , 2005, Journal of Lipid Research.

[8]  J. Breslow,et al.  StAR-related Lipid Transfer (START) Proteins: Mediators of Intracellular Lipid Metabolism* , 2003, Journal of Biological Chemistry.

[9]  J. Bruce German,et al.  Lipid metabolome-wide effects of the PPARγ agonist rosiglitazones⃞s The online version of this article (available at http://www.jlr.org) contains an additional 4 tables. Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200169-JLR200 , 2002, Journal of Lipid Research.

[10]  E. Leiter,et al.  Deconstructing and reconstructing obesity-induced diabetes (diabesity) in mice. , 2002, Diabetes.

[11]  D. Cohen,et al.  Phosphatidylcholine Transfer Protein Promotes Apolipoprotein A-I-mediated Lipid Efflux in Chinese Hamster Ovary Cells* , 2002, The Journal of Biological Chemistry.

[12]  J Bruce German,et al.  Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. , 2002, Journal of lipid research.

[13]  M. Vetting,et al.  Structure of human phosphatidylcholine transfer protein in complex with its ligand , 2002, Nature Structural Biology.

[14]  Y. Sugiyama,et al.  Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi , 2001, Hepatology.

[15]  D. Cohen,et al.  High-level expression and mutagenesis of recombinant human phosphatidylcholine transfer protein using a synthetic gene: evidence for a C-terminal membrane binding domain. , 2000, Biochemistry.

[16]  J. Hurley,et al.  Structure and lipid transport mechanism of a StAR-related domain , 2000, Nature Structural Biology.

[17]  D. Beier,et al.  Cloning, tissue-specific expression, gene structure and chromosomal localization of human phosphatidylcholine transfer protein. , 1999, Biochimica et biophysica acta.

[18]  K. Wirtz,et al.  Mice without phosphatidylcholine transfer protein have no defects in the secretion of phosphatidylcholine into bile or into lung airspaces. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Cohen,et al.  Cloning and gene structure of rat phosphatidylcholine transfer protein, Pctp. , 1999, Gene.

[20]  C. Ponting,et al.  START: a lipid-binding domain in StAR, HD-ZIP and signalling proteins. , 1999, Trends in biochemical sciences.

[21]  D. Cohen,et al.  Baculovirus-mediated expression of recombinant rat phosphatidylcholine transfer protein. , 1998, Journal of lipid research.

[22]  E. Leiter,et al.  NIDDM Genes in Mice: Deleterious Synergism by Both Parental Genomes Contributes to Diabetogenic Thresholds , 1998, Diabetes.

[23]  Geoffrey J. Barton,et al.  JPred : a consensus secondary structure prediction server , 1999 .

[24]  K. Wirtz,et al.  cDNA cloning and tissue-specific expression of the phosphatidylcholine transfer protein gene. , 1996, The Biochemical journal.

[25]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[26]  M. Festing.  Origins and characteristics of inbred strains of mice, 14th listing , 1992 .

[27]  W. Dowhan,et al.  Phospholipid-transfer proteins. , 1991, Current opinion in cell biology.

[28]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[29]  K. Wirtz.  Phospholipid transfer proteins. , 1991, Annual review of biochemistry.

[30]  M. Lyon,et al.  Genetic variants and strains of the laboratory mouse , 1989 .

[31]  E. Triphosphat,et al.  FEBS Letters , 1987, FEBS Letters.

[32]  M. Deol.  Genetic Variants and Strains of the Laboratory Mouse , 1983 .

[33]  D. B. Zilversmit,et al.  Protein-catalyzed exchange of phosphatidylcholine between sonicated liposomes and multilamellar vesicles. , 1977, Biochemistry.

[34]  C. Goodall,et al.  Origin of inbred NZ mouse strains. , 1970, Cancer research.